"Learn how you can get comprehensive cancer care services in a patient-centered environment at Avera Cancer Institute in Mitchell, SD."

During the past decade, Avera Cancer Institute at Yankton conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Avera Cancer Institute at Yankton" #1 collaborator was "National Cancer Institute (NCI)" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Avera Cancer Institute at Yankton" are "Castration-Resistant Prostate Carcinoma" (1 trials), "Extensive Stage Lung Small Cell Carcinoma" (1 trials), "Limited Stage Lung Small Cell Carcinoma" (1 trials), "Lung Small Cell Carcinoma" (1 trials) and "Metastatic Prostate Adenocarcinoma" (1 trials). Many other conditions were trialed in "Avera Cancer Institute at Yankton" in a lesser frequency.

Most popular intervention types in "Avera Cancer Institute at Yankton" are "Drug" (1 trials), "Other" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Degarelix" (1 trials), "Enzalutamide" (1 trials), "Goserelin Acetate" (1 trials), "Leuprolide Acetate" (1 trials) and "Magnetic Resonance Imaging" (1 trials). Other intervention names were less common.

The vast majority of trials in "Avera Cancer Institute at Yankton" are 1 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Avera Cancer Institute at Yankton". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Avera Cancer Institute at Yankton, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Avera Cancer Institute at Yankton, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".